The effect of anti-Parkinsonian drugs on haloperidol-induced inhibition of the conditioned-avoidance response in rats.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001058:Apomorphine / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects*; D001561:Benzilates / Q000494:pharmacology; D003213:Conditioning, Psychological / Q000187:drug effects*; D005021:Ethylamines / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013997:Time Factors
D000978:Antiparkinson Agents; D001561:Benzilates; D005021:Ethylamines; D011437:Propylamines; D011941:Receptors, Adrenergic; D000547:Amantadine; D006220:Haloperidol; D001058:Apomorphine